221
Views
0
CrossRef citations to date
0
Altmetric
Review

Transcatheter tricuspid valve repair and replacement: a landscape review of current techniques and devices for the treatment of tricuspid valve regurgitation

, , , &
Pages 399-411 | Received 18 Jan 2021, Accepted 07 Apr 2021, Published online: 26 Apr 2021

References

  • Asmarats L, Puri R, Latib A, et al. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71(25):2935–2956.
  • Prihadi EA. Tricuspid valve regurgitation: no longer the “forgotten valve.”. ESC E-J Cardiol Pract. 2018;16.
  • Kolte D, Elmariah S. Current state of transcatheter tricuspid valve repair. Cardiovasc Diagn Ther. 2020;10(1):89.
  • Taramasso M, Pozzoli A, Basso C, et al. Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies. EuroIntervention. 2018;13(16):1889–1898.
  • Russo M, Kuwata S, Pozzoli A, et al. Understanding the tricuspid valve for transcatheter valve repair: comparative anatomy of different imaging modalities. Eur Heart J Cardiovasc Imaging. 2017;18(7):823.
  • Chan KJ, Zakkar M, Amirak E, et al. Tricuspid valve disease: pathophysiology and optimal management. Prog Cardiovasc Dis. 2009;51(6):482–486.
  • Topilsky Y, Maltais S, Inojosa JM, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12(3):433–442.
  • Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–409.
  • Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
  • Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(23):2440–2492.
  • Lapenna E, De Bonis M, Verzini A, et al. The clover technique for the treatment of complex tricuspid valve insufficiency: midterm clinical and echocardiographic results in 66 patients. Eur J Cardiothorac Surg. 2010;37(6):1297–1303.
  • McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127(3):674–685.
  • Rodés-Cabau J, Hahn RT, Latib A, et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol. 2016;67(15):1829–1845.
  • Hausleiter J, Braun D, Orban M, et al. Patient selection, echocardiographic screening and treatment strategies for interventional tricuspid repair using the edge-to-edge repair technique. EuroIntervention. 2018;14(6):645–653.
  • Hammerstingl C, Schueler R, Malasa M, et al. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J. 2016;37(10):849–853.
  • Braun D, Orban M, Orban M, et al. Transcatheter edge-to-edge repair for severe tricuspid regurgitation using the triple-orifice technique versus the bicuspidalization technique. JACC: cardiovascular Interventions. 2018;11(17):1790-1792.
  • Besler C, Orban M, Rommel KP, et al. Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge-to-edge repair. JACC Cardiovasc Interv. 2018;11(12):1119–1128.
  • Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation. 2017;135(19):1802–1814.
  • Perlman G, Praz F, Puri R, et al. Transcatheter tricuspid valve repair with a new transcatheter coaptation system for the treatment of severe tricuspid regurgitation: 1-year clinical and echocardiographic results. JACC Cardiovasc Interv. 2017;10(19):1994–2003.
  • Fam NP, Braun D, Von Bardeleben RS, et al. Compassionate use of the PASCAL transcatheter valve repair system for severe tricuspid regurgitation: a multicenter, observational, first-in-human experience. JACC Cardiovasc Interv. 2019;12(24):2488–2495.
  • Hahn RT, Meduri CU, Davidson CJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J Am Coll Cardiol. 2017;69(14):1795–1806.
  • Khan JM, Rogers T, Schenke WH, et al. Transcatheter pledget‐assisted suture tricuspid annuloplasty (PASTA) to create a double‐orifice valve. Catheterization Cardiovasc Interventions. 2018;92(3):E175–E184.
  • Nickenig G, Weber M, Schueler R, et al. 6-month outcomes of tricuspid valve reconstruction for patients with severe tricuspid regurgitation. J Am Coll Cardiol. 2019;73(15):1905–1915.
  • Davidson C, Lim S, Smith R, et al. Early feasibility study of cardioband tricuspid system for functional tricuspid regurgitation: 30 day outcomes. J Am Coll Cardiol. 2020;75(11S1):1132.
  • Nickenig G, Weber M, Schüler R, et al. Two-year outcomes with the cardioband tricuspid system from the multicentre, prospective TRI-REPAIR Study. EuroIntervention. 2021;16(15):e1264-e1271.
  • NCT03700918. A first in human study to assess safety and performance of the davingi™ tr system in the treatment of patients with functional tricuspid regurgitation. 2018. Identifier NCT03700918. https://clinicaltrials.gov/ct2/show/NCT03700918
  • Rogers T, Ratnayaka K, Sonmez M, et al. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv. 2015;8(3):483–491.
  • Hahn RT, George I, Kodali SK, et al. Early single-site experience with transcatheter tricuspid valve replacement. JACC Cardiovasc Imaging. 2019;12(3):416–429.
  • Hahn RT. NAVIGATE transcatheter tricuspid valve replacement early findings–technology and clinical updates. In: Transcatheter cardiovascular therapeutics. From presentation during Transcatheter Therapeutics Conference. San Diego; 2018. p. 23.
  • Lu F, Xu Z, Meng X, et al. TCT-94 A radial force-independent bioprosthesis for transcatheter tricuspid valve implantation: First-in-man clinical trial. J Am Coll Cardiol. 2019;74(13S):B94–B94.
  • Hahn RT, Kodali S, Fam N, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation. Cardiovasc Interventions. 2020;13(21):2482–2493.
  • Bapat VN. The INTREPID valve for severe tricuspid regurgitation: First-in-man case experience. In: Cardiovascular research technologies. From national conference presentation, Cardiovascular Research Technologies. Maryland: National Harbor; 2020 February. p. 22–25.
  • Webb J. Edwards EVOQUE tricuspid valve replacement system. In: Cardiovascular research technologies. From presentation at national conference, Cardiovascular Research Technologies. Maryland: National Harbor; 2020 February. p. 22–25.
  • Lauten A, Figulla HR, Unbehaun A, et al. Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study. Circulation: Cardiovasc Interventions. 2018;11(2):e006061.
  • Mehr M, Taramasso M, Besler C, et al. 1-Year outcomes after edge-to-edge valve repair for symptomatic tricuspid regurgitation: results from the TriValve Registry. JACC Cardiovasc Interv. 2019;12(15):1451–1461.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.